The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

Cited by (396)

Items 101–200 of 396

1. Medical Cannabis for Chronic Nonmalignant Pain Management
   Maha Hameed, Sakshi Prasad, Esha Jain, Bekir Nihat Doğrul, Ahmad Al-Oleimat, Bidushi Pokhrel, Selia Chowdhury, Edzel Lorraine Co, Saloni Mitra, Jonathan Quinonez et al. · 2023 · Current Pain and Headache Reports
2. Cannabidiol (CBD) enhances lipopolysaccharide (LPS)-induced pulmonary inflammation in C57BL/6 mice
   Peer W. F. Karmaus, James G. Wagner, Jack R. Harkema, Norbert E. Kaminski, Barbara L.F. Kaplan · 2012 · Journal of Immunotoxicology
3. Cannabidiol Is a Potential Therapeutic for the Affective-Motivational Dimension of Incision Pain in Rats
   Karina Genaro, Débora Fabris, Ana Luisa Ferreira Arantes, Antônio Waldo Zuardi, José Alexandre S. Crippa, Wiliam A. Prado · 2017 · Frontiers in Pharmacology
4. Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice
   Harshini Neelakantan, Ronald J. Tallarida, Zachary Wilmer Reichenbach, Ronald F. Tuma, Sara Jane Ward, Ellen Ann Walker · 2014 · Behavioural Pharmacology
5. Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
   George Jîtcă, Bianca Eugenia Ősz, Camil-Eugen Vari, Carmen-Maria Rusz, Amelia Tero-Vescan, Amalia Puşcaş · 2023 · Antioxidants
6. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative
   Nicole Rodrigues da Silva, Felipe V. Gomes, Miriam M. Fonseca, Raphael Mechoulam, Aviva Breuer, Thiago M. Cunha, Francisco Silveira Guimarães · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
7. Effects of cannabidiol, a Cannabis sativa constituent, on oral wound healing process in rats: Clinical and histological evaluation
   M. J. Klein, JULIANE DE QUADROS DE BORTOLLI, Francisco Silveira Guimarães, Fernanda Gonçalves Salum, Karen Cherubini, Maria Antonia Zancanaro de Figueiredo · 2018 · Phytotherapy Research
8. Molecular and Biochemical Mechanism of Cannabidiol in the Management of the Inflammatory and Oxidative Processes Associated with Endometriosis
   Tiziana Genovese, Marika Cordaro, Rosalba Siracusa, Daniela Impellizzeri, Sebastiano Caudullo, Emanuela Raffone, Francesco Macrı̀, Livia Interdonato, Enrico Gugliandolo, Claudia Dina Interlandi et al. · 2022 · International Journal of Molecular Sciences
9. Neuroprotective Effects of Genistein in Mongolian Gerbils: Estrogen Receptor–β Involvement
   Andrea Donzelli, Daniela Braida, Annamaria Finardi, Valeria Capurro, Anna Elisa Valsecchi, Mariapia Colleoni, Mariaelvina Sala · 2010 · Journal of Pharmacological Sciences
10. Cannabinoid receptors and pain
    Katarzyna Starowicz, Natalia Małek, Barbara Przewłocka · 2013 · Wiley Interdisciplinary Reviews Membrane Transport and Signalling
11. The therapeutic potential of the endocannabinoid system for Alzheimer's disease
    Tim Karl, David Cheng, Brett Garner, Jonathon Carl Arnold · 2012 · Expert Opinion on Therapeutic Targets
12. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: Comparison of reserpine-induced myalgia and chronic constriction injury rats
    Yukinori Nagakura, Masayasu Takahashi, Takahisa Noto, Toshihiro Sekizawa, Tomoya Oe, Eiji Yoshimi, Keisuke Tamaki, Yasuaki Shimizu · 2011 · Behavioural Brain Research
13. Oral efficacy of Δ(9)-tetrahydrocannabinol and cannabidiol in a mouse neuropathic pain model
    Vanessa A. Mitchell, Juliette Cornelia Harley, Sherelle L. Casey, Arabella Charlotte Vaughan, Bryony L. Winters, Christopher Walter Vaughan · 2021 · Neuropharmacology
14. Treatment of neuropathic pain with plant medicines
    Garima Garg, James David Adams Jr. · 2012 · Chinese Journal of Integrative Medicine
15. Potential role of cannabidiol in Parkinson’s disease by targeting the WNT/β-catenin pathway, oxidative stress and inflammation
    Alexandre Vallée, Jean-Noël Vallée, Yves Lecarpentier · 2021 · Aging
16. Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators
    Lukas K. Peltner, Lars Gluthmann, Friedemann R. Börner, S. Pace, R. K. Hoffstetter, C. Kretzer, Rosella Bilancia, F. Pollastro, A. Koeberle, G. Appendino et al. · 2023 · Cell Chemical Biology
17. Cannabidiol (CBD) induces functional Tregs in response to low-level T cell activation
    Saphala Dhital, John V. Stokes, Nogi Park, Keun Seok Seo, Barbara L.F. Kaplan · 2016 · Cellular Immunology
18. The Current and Potential Application of Medicinal Cannabis Products in Dentistry
    Henry I. C. Lowe, Ngeh J. Toyang, Blair Steele, Joseph Bryant, Wilfred F. Ngwa, Kaveh Nedamat · 2021 · Dentistry Journal
19. Cannabigerol ( CBG ) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy
    Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, Dongxiao Sun, Kent E. Vrana, Nicholas Graziane · 2022 · European Journal of Pain
20. Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
    Ronit Vogt Sionov, Doron Steinberg · 2022 · Biomedicines
21. Anti-inflammation and gingival wound healing activities of Cannabis sativa L. subsp. sativa (hemp) extract and cannabidiol: An in vitro study
    Kheskanya Kongkadee, Wudtichai Wisuitiprot, Kornkanok Ingkaninan, Neti Waranuch · 2022 · Archives of Oral Biology
22. Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress
    Veronica Cocetta, Paolo Governa, Vittoria Borgonetti, Mattia Tinazzi, Gregorio Peron, Daniela Catanzaro, Massimiliano Berretta, Marco Biagi, Fabrizio Manetti, Stefano Dall’Acqua et al. · 2021 · Frontiers in Pharmacology
23. Comprehending and improving cannabis specialized metabolism in the systems biology era
    Paco Romero, Arnau Peris-Cuesta, Karina Vergara, José Tomás Matus · 2020 · Plant Science
24. Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-Induced Neuropathic Pain in Rodents
    Anil Kumar Kalvala, Arvind Bagde, Peggy Arthur, Sunil Kumar Surapaneni, Ramesh Nimma, Aakash Nathani, Mandip S. Singh · 2021 · International Immunopharmacology
25. Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review
    Adarsh Thomas Anthony, Shermeen Rahmat, Prerna Sangle, Osama Sandhu, Safeera Khan · 2020 · Cureus
26. Protective Effects of Cannabidiol on Lesion-Induced Intervertebral Disc Degeneration
    J.W.S. Silveira, Ana Carolina Issy, Vitor Castania, Carlos Ernesto Garrido Salmón, Marcello Henrique Nogueira‐Barbosa, Francisco Silveira Guimarães, Helton Luíz Aparecido Defino, Elaine Aparecida Del Bel · 2014 · PLoS ONE
27. Antioxidant and Anti‐inflammatory Effect of Cannabidiol Contributes to the Decreased Lipid Peroxidation of Keratinocytes of Rat Skin Exposed to UV Radiation
    Anna Jastrząb, Iwona Jarocka-Karpowicz, Agnieszka Markowska, Adam Wroński, Agnieszka Gęgotek, Elźbieta Skrzydlewska · 2021 · Oxidative Medicine and Cellular Longevity
28. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products
    Jinpeng Li, Ricardo Carvajal, Leon H. Bruner, Norbert E. Kaminski · 2021 · Food and Chemical Toxicology
29. Alternative treatment strategies for neuropathic pain: Role of Indian medicinal plants and compounds of plant origin-A review
    H.B. Singh, Sakshi Bhushan, Rohit Arora, Harpal Singh Buttar, Saroj Arora, Balbir Singh · 2017 · Biomedicine & Pharmacotherapy
30. Cannabidiol-induced lymphopenia does not involve NKT and NK cells.
    Bogna Marta Ignatowska-Jankowska, Maciej M. Jankowski, Wojciech Glac, A H Swiergel · 2009 · PubMed
31. Cannabinoid control of neurogenic inflammation
    Meagan McKenna, Jason J. McDougall · 2020 · British Journal of Pharmacology
32. Total Phenolic Content and Antioxidant Activity of In Vitro Digested Hemp-Based Products
    Davide Lanzoni, Eva Skřivanová, R. Rebucci, Antonio Crotti, Antonella Baldi, Luca Marchetti, Carlotta Giromini · 2023 · Foods
33. Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · International Journal of Molecular Sciences
34. Non-psychotropic analgesic drugs from the endocannabinoid system: “Magic bullet” or “multiple-target” strategies?
    Katarzyna Starowicz, Vincenzo Di Marzo · 2013 · European Journal of Pharmacology
35. Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception
    L.D. Ellis, Fabrice Berrué, Michael G. Morash, John C. Achenbach, J. Hill, Jason J. McDougall · 2017 · Behavioural Brain Research
36. Cannabinoid treatments for anxiety: A systematic review and consideration of the impact of sleep disturbance
    Andrea J. Narayan, Luke A. Downey, Brooke Manning, Amie C. Hayley · 2022 · Neuroscience & Biobehavioral Reviews
37. Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
    Guillermo Cásedas, Martín de Yarza-Sancho, Víctor López · 2024 · Pharmaceuticals
38. Cannabinoids Δ9-tetrahydrocannabinol and cannabidiol may be effective against methamphetamine induced mitochondrial dysfunction and inflammation by modulation of Toll-like type-4(Toll-like 4) receptors and NF-κB signaling
    Fatemeh Majdi, Fereshteh Taheri, Pegah Salehi, Majid Motaghinejad, Sepideh Safari · 2019 · Medical Hypotheses
39. Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia
    Gerwyn Morris, Luba Sominsky, Kenneth R. Walder, Michael Berk, Wolfgang Marx, Andre Ferrer Carvalho, Chiara C. Bortolasci, Michael H. J. Maes, Basant K. Puri · 2022 · Molecular Neurobiology
40. Modulation of T-type calcium channels by bioactive lipids
    Jean Chemin, Magali Cazade, Philippe Lory · 2014 · Pflügers Archiv - European Journal of Physiology
41. In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils
    Mohammad Shajid Ashraf Junaid, Akeemat O. Tijani, Ashana Puri, Ajay K. Banga · 2022 · International Journal of Pharmaceutics
42. Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
    Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes · 2023 · Pharmaceuticals
43. Cannabidiol hydroxyquinone-induced apoptosis of splenocytes is mediated predominantly by thiol depletion
    Hsin‐Ying Wu, Tong‐Rong Jan · 2010 · Toxicology Letters
44. Evaluation of the preclinical analgesic efficacy of naturally derived, orally administered oil forms of Δ9-tetrahydrocannabinol (THC), cannabidiol (CBD), and their 1:1 combination
    Katja Linher‐Melville, Yong Fang Zhu, Jesse Sidhu, Natalka Parzei, Ayesha Shahid, Gireesh Seesankar, Danny Ma, Zhi Wang, Natalie Zacal, Manu Sharma et al. · 2020 · PLoS ONE
45. Cannabidiol promotes adipogenesis of human and mouse mesenchymal stem cells via PPARγ by inducing lipogenesis but not lipolysis
    Richard Cheng-An Chang, Chloe S. Thangavelu, Erika M. Joloya, Yun Kuo, Zhuorui Li, Bruce Blumberg · 2022 · Biochemical Pharmacology
46. Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy
    Mariana Babayeva, Haregewein Assefa, Paramita Basu, Sanjeda R Chumki, Zvi G. Loewy · 2016 · Parkinson s Disease
47. Involvement of glycine receptor α1 subunits in cannabinoid-induced analgesia
    Jie-Ping Lu, Sijia Fan, Guichang Zou, Yiwen Hou, Tao Pan, Weiwei Guo, Lei Yao, Feng Du, Gregg E. Homanics, Dan Liu et al. · 2018 · Neuropharmacology
48. Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol
    Cinzia Citti, Federica Palazzoli, Manuela Licata, Antonietta Vilella, Giuseppina Leo, Michèle Zoli, Maria Angela Vandelli, Flavio Forni, Barbara Pacchetti, Giuseppe Cannazza · 2018 · Journal of Pharmaceutical and Biomedical Analysis
49. Cannabidiol in sport: Ergogenic or else?
    François-Xavier Gamelin, Grégory Cuvelier, Antoine Mendes, Julien Aucouturier, Serge Berthoin, Vincenzo Di Marzo, Elsa Heyman · 2020 · Pharmacological Research
50. Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)
    Tobias Schneider, Laura Zurbriggen, Markus Dieterle, Eckhard Mauermann, Priska Frei, Katja Mercer‐Chalmers‐Bender, Wilhelm Ruppen · 2021 · Pain
51. Feeding Cannabidiol (CBD)-Containing Treats Did Not Affect Canine Daily Voluntary Activity
    Elizabeth M. Morris, Susanna E. Kitts-Morgan, Dawn M. Spangler, Jessica E. Gebert, Eric S. Vanzant, Kyle R. McLeod, David Lee Harmon · 2021 · Frontiers in Veterinary Science
52. Sciatic nerve transection increases gluthatione antioxidant system activity and neuronal nitric oxide synthase expression in the spinal cord
    Renata Padilha Guedes, Lidiane Dal Bosco, Alex Sander da Rosa Araújo, Adriane Belló‐Klein, Maria Flávia Marques Ribeiro, Wania Aparecida Partata · 2009 · Brain Research Bulletin
53. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease
    Estefanía Moreno, Milena R. Cavic, Enric I. Canela · 2021 · International Journal of Molecular Sciences
54. Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice
    Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, Dongxiao Sun, Kent E. Vrana, Nicholas Graziane · 2021 · Cannabis and Cannabinoid Research
55. Cannabidiol modulation of antinociceptive tolerance to Δ9-tetrahydrocannabinol
    Nicholas Z. Greene, Jenny L. Wiley, Zhihao Yu, Brian H. Clowers, Rebecca M. Craft · 2018 · Psychopharmacology
56. The Effects of Marijuana Use on Lumbar Spinal Fusion
    Andre M. Jakoi, Gregory Joseph Kirchner, Yehuda E. Kerbel, Justin A. Iorio, Amrit S. Khalsa · 2019 · Spine
57. Restoring glutamate homeostasis in the nucleus accumbens via endocannabinoid-mimetic drug prevents relapse to cocaine seeking behavior in rats
    Lan-Yuan Zhang, Yue-Qing Zhou, Zhipeng Yu, Xiaoqin Zhang, Jie Shi, Haowei Shen · 2021 · Neuropsychopharmacology
58. Evaluation of cannabidiol nanoparticles and nanoemulsion biodistribution in the central nervous system after intrathecal administration for the treatment of pain
    Paula Muresan, Stephen G. Woodhams, Fiona N.C. Smith, Vincenzo Taresco, Jaymin Arvind Shah, Mei Wong, Victoria Chapman, Stuart James Smith, Gareth J. Hathway, Ruman Rahman et al. · 2023 · Nanomedicine Nanotechnology Biology and Medicine
59. Cannabis against chronic musculoskeletal pain: a scoping review on users and their perceptions
    Daniela Furrer, Edeltraut Kröger, Martine Marcotte, Nathalie Jauvin, Richard E. Bélanger, Mark A. Ware, Guillaume Foldes‐Busque, Michèle Aubin, Pierre Pluye, Clermont E. Dionne · 2021 · Journal of Cannabis Research
60. Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)
    Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, Katja Mercer‐Chalmers‐Bender, Priska Frei, Wilhelm Ruppen, Tobias Schneider · 2022 · Pain
61. Hemp in Animal Diets—Cannabidiol
    Sepideh Fallahi, Łukasz Bobak, Sebastian Opaliński · 2022 · Animals
62. Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial
    Chalapinyo Umpreecha, Kanokporn Bhalang, Dusadee Charnvanich, Jittima Amie Luckanagul · 2023 · BMC Complementary Medicine and Therapies
63. The endocannabinoid system in migraine: from bench to pharmacy and back
    Cristina Tassorelli, Rosaria Greco, Stephen David Silberstein · 2019 · Current Opinion in Neurology
64. Changes in Lipid Profile of Keratinocytes from Rat Skin Exposed to Chronic UVA or UVB Radiation and Topical Application of Cannabidiol
    Wojciech Łuczaj, M. Rosário Domingues, Pedro M. Domingues, Elźbieta Skrzydlewska · 2020 · Antioxidants
65. Topical Cannabinoids for Treating Chemotherapy-Induced Neuropathy: A Case Series
    Stacy D. D’Andre, Sean D. McAllister, Jasdeepa Nagi, Karthik V. Giridhar, Eduardo Ruiz-Macias, Charles L. Loprinzi · 2021 · Integrative Cancer Therapies
66. Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects
    Sara Jane Ward, Aron H. Lichtman, Daniele Piomelli, Linda A. Parker · 2021 · JNCI Monographs
67. Medicinal Cannabis and Central Nervous System Disorders
    Yuma T. Ortiz, Lance Richard McMahon, Jenny L. Wilkerson · 2022 · Frontiers in Pharmacology
68. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model
    Sherelle L. Casey, Vanessa A. Mitchell, Eddy E. Sokolaj, Bryony L. Winters, Christopher Walter Vaughan · 2022 · International Journal of Molecular Sciences
69. Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
    Anjalika Eeswara, Amanda Pacheco-Spiewak, Stanislava Jergová, Jacqueline Sagen · 2023 · PLoS ONE
70. Cannabinoids and endocannabinoids as therapeutics for nervous system disorders: preclinical models and clinical studies
    R. Scott Duncan, Sean M. Riordan, Matthew C. Gernon, Peter Koulen · 2023 · Neural Regeneration Research
71. Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
    Luísa Rocha, Christian Lizette Frías‐Soria, José G. Ortíz, Jerónimo Auzmendi, Alberto Lazarowski · 2020 · Epilepsia Open
72. Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain
    Alex Mabou Tagne, Yannick Fotio, Lin Lin, Erica Squire, Faizy Ahmed, Tarif Ibne Rashid, Elnaz Karimian Azari, Daniele Piomelli · 2021 · Pharmacological Research
73. The Potential Use of Cannabis in Tissue Fibrosis
    Nazar Pryimak, Mariia Zaiachuk, Olga Kovalchuk, Igor Kovalchuk · 2021 · Frontiers in Cell and Developmental Biology
74. Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America
    Richard Quansah Amissah, Nadine A. Vogt, Chuyun Chen, Karolina Urban, Jibran Younis Khokhar · 2022 · PLoS ONE
75. Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model
    Carlos Henrique Alves Jesus, Matheus Vinícius Ferreira, Aléxia Thamara Gasparin, Evelize Stacoviaki Rosa, Karina Genaro, José Alexandre S. Crippa, Juliana Geremias Chichorro, Joice Maria da Cunha · 2022 · Behavioural Brain Research
76. Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
    Rosaria Greco, Miriam Francavilla, Chiara Demartini, Anna Maria Zanaboni, Mikael Hans Sodergren, Sara Facchetti, Barbara Pacchetti, Michela Palmisani, Valentina Franco, Cristina Tassorelli · 2023 · The Journal of Headache and Pain
77. The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig
    A. Dudášová, Sandra D. Keir, Michael E. Parsons, Areles Molleman, Clive Peter Page · 2013 · Pulmonary Pharmacology & Therapeutics
78. Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases
    Amber Cintosun, Irene Lara‐Corrales, Elena Pope · 2020 · Clinical Drug Investigation
79. Cannabidiol effectively prevents oxidative stress and stabilizes hypoxia-inducible factor-1 alpha (HIF-1α) in an animal model of global hypoxia
    Hanna Kletkiewicz, Michał S. Wojciechowski, Justyna Rogalska · 2024 · Scientific Reports
80. Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model
    G.H. Callejas, Rebeca Lopes Figueira, Frances Lilian Lanhellas Gonçalves, Fábio Antônio Perecim Volpe, Antônio Waldo Zuardi, José A. S. Crippa, Jaime E. C. Hallak, Lourenço Sbragia · 2018 · Brazilian Journal of Medical and Biological Research
81. Cannabidiol activation of vagal afferent neurons requires TRPA1
    Cody W. Kowalski, Forrest J. Ragozzino, Jonathan E. M. Lindberg, BreeAnne Peterson, Janelle M. Lugo, Ryan J. McLaughlin, James Henry Peters · 2020 · Journal of Neurophysiology
82. Eicosanoid mediation of cannabinoid actions
    SUMNER H. BURSTEIN · 2019 · Bioorganic & Medicinal Chemistry
83. Possible actions of cannabidiol in obsessive-compulsive disorder by targeting the WNT/β-catenin pathway
    Alexandre Vallée, Yves Lecarpentier, Jean-Noël Vallée · 2021 · Molecular Psychiatry
84. Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence
    Farnaz Ebrahimi, Mohammad Hosein Farzaei, Roodabeh Bahramsoltani, Mojtaba Heydari, Kiana Naderinia, Roja Rahimi · 2019 · Reviews in the Neurosciences
85. Molecular Mechanisms Through Which Cannabidiol May Affect Skeletal Muscle Metabolism, Inflammation, Tissue Regeneration, and Anabolism: A Narrative Review
    Moniek Schouten, Sebastiaan Dalle, Katrien Koppo · 2022 · Cannabis and Cannabinoid Research
86. Understanding the complex pharmacology of cannabidiol: Mounting evidence suggests a common binding site with cholesterol
    Lewis J. Martin, Samuel D. Banister, Michael T. Bowen · 2021 · Pharmacological Research
87. Effect of Cannabinoid Receptor Agonists on Streptozotocin-Induced Hyperalgesia in Diabetic Neuropathy
    Bujalska, Magdalena · 2008 · Pharmacology
88. Cellular distribution of cannabinoid‐related receptors TRPV1, PPAR‐gamma, GPR55 and GPR3 in the equine cervical dorsal root ganglia
    Giorgia Galiazzo, Margherita De Silva, Fiorella Giancola, Riccardo Rinnovati, Angelo Peli, Roberto Chiocchetti · 2021 · Equine Veterinary Journal
89. An Overview of Cannabidiol
    Alexandra Sideris, Lisa Doan · 2023 · Anesthesia & Analgesia
90. Role of Cannabinoids in the Management of Neuropathic Pain
    María Isabel Martín Fontelles, Carlos Goicoechea · 2008 · CNS Drugs
91. Prevalence of Cannabidiol Use in Patients With Spine Complaints: Results of an Anonymous Survey
    Francis Campana Lovecchio, Mark T. Langhans, Tianna Bennett, Michael E. Steinhaus, Ajay Premkumar, Matthew E. Cunningham, James Farmer, Todd James Albert, Russel C. Huang, Yoshihiro Katsuura et al. · 2021 · The International Journal of Spine Surgery
92. Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives
    Gleice Kelli Silva-Cardoso, Christie Ramos Andrade Leite‐Panissi · 2022 · Cannabis and Cannabinoid Research
93. Peripherally injected canabidiol reduces neuropathic pain in mice: Role of the 5-HT1A and TRPV1 receptors
    Danielle Diniz Aguiar, Cristina da Costa Oliveira, Flávia Cristina de Sousa Fonseca, Douglas Lamounier de Almeida, William Valadares Campos Pereira, Francisco Silveira Guimarães, Andréa C. Perez, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero · 2023 · Biochemical and Biophysical Research Communications
94. Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy
    Magdalena Bujalska‐Zadrożny, Anna de Cordé, Karolina Pawlik · 2014 · Pharmacological Reports
95. Alterations in the Anandamide Metabolism in the Development of Neuropathic Pain
    Natalia Małek, Mateusz Wojciech Kucharczyk, Katarzyna Starowicz · 2014 · BioMed Research International
96. Formulation and Chemical Stability in Aqueous Media of Cannabidiol Embedded in Cardanol-Based Nanovesicles
    Maria Pia Di Bello, Ermelinda Bloise, Selma Elaine Mazzetto, Giuseppe Mele · 2017 · ACS Sustainable Chemistry & Engineering
97. Cannabis and Turmeric as Complementary Treatments for IBD and Other Digestive Diseases
    Sandra M. Quezada, Raymond Keith Cross · 2019 · Current Gastroenterology Reports
98. Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases
    Martin Helcman, Karel Šmejkal · 2021 · Phytochemistry Reviews
99. Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model
    Elham Rouhollahi, Bernard A. MacLeod, Alasdair M. Barr, E. Puil · 2020 · Drug Design Development and Therapy
100. Cannabis sativa as a Treatment for Obesity: From Anti-Inflammatory Indirect Support to a Promising Metabolic Re-Establishment Target
     Eulla Keimili Fernandes Ferreira Cavalheiro, Ana Beatriz Costa, Daniéle Hendler Salla, Mariella Reinol da Silva, Talita Farias Mendes, Larissa Espindola da Silva, Cristini da Rosa Turatti, Rafael Mariano de Bitencourt, Gislaine Tezza Rezin · 2021 · Cannabis and Cannabinoid Research